» Articles » PMID: 26692014

Molecular Basis of Antibody Binding to Mucin Glycopeptides in Lung Cancer

Overview
Journal Int J Oncol
Specialty Oncology
Date 2015 Dec 23
PMID 26692014
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Glycopeptides bearing Tn epitopes are emerging targets for cancer diagnosis and immunotherapy. In this study, we analyzed membrane proteins containing O-glycosylated tandem repeat (TR) sequences in lung cancer patients of different types and stages, using gene microarray data in public domain. The expression of Tn and glycopeptide epitopes on the surface of lung cancer cell lines were studied by monoclonal IgG antibodies 14A, 16A, and B72.3. The binding of mAbs to synthetic glycopeptides were studied by surface plasmon resonance. Nine mucin mRNAs were found to be expressed in lung cancer patients but at similar level to healthy individuals. At protein level, a glycopeptide epitope on cancer cell surface is preferably recognized by mAb 16A, as compared to peptide-alone (14A) or sugar-alone epitopes (B72.3). 14A and 16A favor clustered TR containing more than three TR sequences, with 10-fold lower Kd than two consecutive TR. B72.3 preferrably recognized clustered sialyl-Tn displayed on MUC1 but not other O-glycoproteins, with 100-fold stronger binding when MUC1 is transfected as a sugar carrier, while the total sugar epitopes remain unchanged. These findings indicate that clusters of both TR backbones and sugars are essential for mAb binding to mucin glycopeptides. Three rules of antibody binding to mucin glycopeptides at molecular level are presented here: first, the peptide backbone of a glycopeptide is preferentially recognized by B cells through mutations in complementarity determining regions (CDRs) of B cell receptor, and the sugar-binding specificity is acquired through mutations in frame work of heavy chain; secondly, consecutive tandem repeats (TR) of peptides and glycopeptides are preferentially recognized by B cells, which favor clustered TR containing more than three TR sequences; thirdly, certain sugar-specific B cells recognize and accommodate clustered Tn and sialyl-Tn displayed on the surface of a mucin but not other membrane proteins.

Citing Articles

Unraveling -Glycan Diversity of Mucins: Insights from SmE Mucinase and Ultraviolet Photodissociation Mass Spectrometry.

Helms A, Chang V, Malaker S, Brodbelt J Anal Chem. 2024; 96(49):19230-19237.

PMID: 39576755 PMC: 11653425. DOI: 10.1021/acs.analchem.4c02011.


Mining the Immunopeptidome for Antigenic Peptides in Cancer.

Leon-Letelier R, Katayama H, Hanash S Cancers (Basel). 2022; 14(20).

PMID: 36291752 PMC: 9599891. DOI: 10.3390/cancers14204968.


Differential expression by epigenetic alterations in human lung squamous cell carcinoma and adenocarcinoma.

Lin S, Tian C, Li J, Liu B, Ma T, Chen K Oncol Rep. 2021; 45(5).

PMID: 33786615 PMC: 8020203. DOI: 10.3892/or.2021.8029.


A novel Tn antigen epitope-recognizing antibody for MUC1 predicts clinical outcome in patients with primary lung adenocarcinoma.

Kato T, Ujiie H, Hatanaka K, Nange A, Okumura A, Tsubame K Oncol Lett. 2021; 21(3):202.

PMID: 33574941 PMC: 7816362. DOI: 10.3892/ol.2021.12463.


An antibody-drug conjugate targeting a GSTA glycosite-signature epitope of MUC1 expressed by non-small cell lung cancer.

Pan D, Tang Y, Tong J, Xie C, Chen J, Feng C Cancer Med. 2020; 9(24):9529-9540.

PMID: 33084221 PMC: 7774737. DOI: 10.1002/cam4.3554.


References
1.
Ramanathan R, Lee K, McKolanis J, Hitbold E, Schraut W, Moser A . Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer. Cancer Immunol Immunother. 2004; 54(3):254-64. PMC: 11034344. DOI: 10.1007/s00262-004-0581-1. View

2.
Longenecker B, Willans D, MacLean G, Selvaraj S, Suresh M, Noujaim A . Monoclonal antibodies and synthetic tumor-associated glycoconjugates in the study of the expression of Thomsen-Friedenreich-like and Tn-like antigens on human cancers. J Natl Cancer Inst. 1987; 78(3):489-96. View

3.
Forsstrom B, AxnAs B, Stengele K, Buhler J, Albert T, Richmond T . Proteome-wide epitope mapping of antibodies using ultra-dense peptide arrays. Mol Cell Proteomics. 2014; 13(6):1585-97. PMC: 4047477. DOI: 10.1074/mcp.M113.033308. View

4.
Matsumoto-Takasaki A, Hanashima S, Aoki A, Yuasa N, Ogawa H, Sato R . Surface plasmon resonance and NMR analyses of anti Tn-antigen MLS128 monoclonal antibody binding to two or three consecutive Tn-antigen clusters. J Biochem. 2011; 151(3):273-82. DOI: 10.1093/jb/mvr138. View

5.
Wilson C, Miller C . Simpleaffy: a BioConductor package for Affymetrix Quality Control and data analysis. Bioinformatics. 2005; 21(18):3683-5. DOI: 10.1093/bioinformatics/bti605. View